Abstract
Osteoarthritis is one of the most common diseases, and it affects 12% of the population around the world. Although the disease is chronic, it significantly reduces the patient’s quality of life. At present, stem cell therapy is considered to be an efficient approach for treating this condition. Mesenchymal stem cells (MSCs) show the most potential for stem cell therapy of osteoarthritis. In fact, MSCs can differentiate into certain mesodermal tissues such as cartilage and bone. Therefore, in the present study, we applied adipose tissue-derived MSCs to osteoarthritis treatment. This study aimed to evaluate the clinical efficiency of autologous adipose tissue-derived MSC transplantation in patients with confirmed osteoarthritis at grade II and III. Adipose tissue was isolated from the belly, and used for extraction of the stromal vascular fraction (SVF). The SVF was mixed with activated platelet-rich plasma before injection. The clinical efficiencies were evaluated by the pain score (VAS), Lysholm score, and MRI findings. We performed the procedure in 21 cases from 2012 to 2013. All 21 patients showed improved joint function after 8.5 months. The pain score decreased from 7.6±0.5 before injection to 3.5±0.7 at 3 months and 1.5±0.5 at 6 months after injection. The Lysholm score increased from 61±11 before injection to 82±8.1 after injection. Significant improvements were noted in MRI findings, with increased thickness of the cartilage layer. Moreover, there were no side-effects or complications related to microorganism infection, graft rejection, or tumorigenesis. These results provide a new opportunity for osteoarthritis treatment. Level of evidence: IV.
Highlights
Cartilage injury is a common clinical condition, especially in people aged over 40 years
We performed this clinical trial with the aim of evaluating the efficiency and side-effects of nonexpanded stromal vascular fraction (SVF) transplantation in combination with platelet-rich plasma (PRP) in osteoarthritis grade II and III
We evaluated the in vitro and animal model effects of platelet-rich plasma (PRP) on Adipose derived stem cell (ADSC) differentiation into chondrocytes
Summary
Cartilage injury is a common clinical condition, especially in people aged over 40 years. There were no non-beneficial effects from ADSC or SVF transplantation recorded in the animal models (Van Pham et al, 2013a) Based on these results, we performed this clinical trial with the aim of evaluating the efficiency and side-effects of nonexpanded SVF transplantation in combination with PRP in osteoarthritis grade II and III. The SVF was isolated using an ADSC Extraction Kit (GeneWorld, Ho Chi. In previously published studies, we evaluated the in vitro and animal model (mice) effects of platelet-rich plasma (PRP) on ADSC differentiation into chondrocytes. We showed that PRP treatment of ADSCs promoted their differentiation and proliferation into chondrogenic cells (Van Pham et al, 2013a) These cells strongly expressed collagen II, Sox, and aggrecan. All patients were examined after collection of aspirated adipose tissue and peripheral blood to obtain the SVF and activated PRP. The patients waited in the surgery room for 2 h before receiving the injected mixture of SVF and PRP without joint surgery
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
